Obesity and metabolic changes are common in young childhood brain tumor survivors

Pediatric Blood and Cancer

Volumn 52, Issue 7, 2009, Pages 853-859

  Pietilä, Sari ^a   Mäkipernaa, Anne ^b   Sievänen, Harri ^c   Koivisto, Anna Maija ^d   Wigren, Tuija ^a   Lenko, Hanna L ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Brain tumor; Childhood; Dyslipidemia; Late effects; Metabolic syndrome; Obesity

Indexed keywords

ANTINEOPLASTIC AGENT; GLUCOSE; GROWTH HORMONE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROXINE; URIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CHOLESTEROL BLOOD LEVEL; CHOROID PLEXUS TUMOR; CRANIOPHARYNGIOMA; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; EPENDYMOMA; FEMALE; GERM CELL TUMOR; GLIOMA; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HAMARTOMA; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERURICEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; HYPOTHALAMUS LESION; HYPOTHALAMUS TUMOR; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; METABOLIC SYNDROME X; OBESITY; OLIGODENDROGLIOMA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SKULL IRRADIATION; THYROID FUNCTION; URIC ACID BLOOD LEVEL; WALKING DIFFICULTY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; OBESITY; SURVIVAL RATE; YOUNG ADULT;

EID: 67650432513     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21936     Document Type: Article

References (40)

1. Talvensaari KK, Lanning M, Tapanainen P, et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endoc Metab 1996;81:3051-3055. (Pubitemid 26323907)
2. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al. Impaired glucose tolerance and dyslipidemia as late effects after bone marrow transplantation in childhood. Lancet 2000;356:993-997.
3. Heikens J, Ubbink MC, van der PalHP, et al. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer 2000;88:2116-2121. (Pubitemid 30233214)
4. Pietilä S, Ala-Houhala M, Lenko HL, et al. Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment. Pediatr Blood Cancer 2005;44:363-369. (Pubitemid 40316029)
5. Sorva R, Perheentupa J, Tolppanen EM. New format for a growth chart. Acta Paediatr Scand 1984;16:495-506.
6. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, and stages of puberty. Arch Dis Child 1976;51:170-182.
7. Fogelholm M, Kukkonen-Harjula K, Sievänen H, et al. Body composition assessment in lean and normal-weight young women. Br J Nutr 1996;75:793-802. (Pubitemid 26237661)
8. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Worldwide definition for use in clinical; practice. Berlin, 2005.
9. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-A new worldwide definition. Lancet 2005;366:1059-1062. (Pubitemid 41338752)
10. McCarthy HD, Ashwell M. A study of central fatness using waistto-height ratios in UK children and adolescents over two decades supports the simple message-'keep your waist circumference to less than half your height'. Int J Obes 2006;30:988-992. (Pubitemid 43801201)
11. Joint National Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-2446. (Pubitemid 27517978)
12. Rosner B, Prineas RJ, Loggie JMH, et al. Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States. J Pediatr 1993;123:871-886. (Pubitemid 23353249)
13. Zimmet P, Alberti G, Kaufman F, et al. International diabetes federation task force on epidemiology and prevention of diabetes: The metabolic syndrome in children and adolescents. Lancet 2007;369:2059-2061.
14. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24:1601-1610.
15. Hakanen M, Lagström H, Kaitosaari T, et al. Development of overweight in an atherosclerosis prevention trial starting in early childhood. The STRIP study. Int J Obes 2006;30:618-626.
16. Higgins PB, Gower BA, Hunter GR, et al. Defining healthrelated obesity in prepubertal children. Obes Res 2001;9:233-240. (Pubitemid 33603842)
17. van der Sluis IM, de Ridder MAJ, Boot AM, et al. Reference data for bone density and body composition measured with dual energy X ray absorptiometry in white children and young adults. Arch Dis Child 2002;87:341-347.
18. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689. (Pubitemid 32893993)
19. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes. Diabetes Care 2003;26:3153-3159.
20. Rönnemaa T, Knip M, Lautala P, et al. Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med 1991;23:67-72.
21. Vanhala MJ, Vanhala PT, Keinänen-Kiukaanniemi SM, et al. Relative weight gain and obesity as child predict metabolic syndrome as adult. Int J Obes Relat Metab Disord 1999;23:656-659. (Pubitemid 29276817)
22. Katzmarzyk PT, Perusse L, Malina RM, et al. Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: The Quebeck Family Study. J Clin Epidemiol 2001;54:190-195. (Pubitemid 32112377)
23. Mattsson N, Rönnemaa T, Juonala M, et al. Arterial structure and function in young adults with metabolic syndrome: The Cardiovascular Risk in Young Finns Study. Eur Heart J 2008;29:784-791.
24. Reilly JJ, Dorosty AR, Emmett PM, et al. Identification of the obese child: Adequacy of the body mass index for clinical practise and epidemiology. Int J Obes Relat Metab Disord 2000;24:1623-1627.
25. Daniels SR, Khoury PR, Morrison JA. The utility of body mass index as a measure of body fatness in children and adolescents: Differences by race and gender. Pediatrics 1997;99:804-807. (Pubitemid 27231351)
26. Didi M, Didcock E, Davies HA, et al. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr 1995;127:63-67.
27. Oeffinger KC, Buchanan GR, Eshelman DA, et al. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2001;23:424-430. (Pubitemid 33031770)
28. Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukaemia: A report from the Childhood Cancer Survivor Study. J Clin Oncol 2003;21: 1359-1365. (Pubitemid 46606416)
29. Kautiainen S, Rimpelä A, Vikat A, et al. Secular trends in overweight and obesity among Finnish adolescents in 1977-1999. Int J Obes Relat Metab Disor 2002;26:544-552.
30. Lustig RH, Post SR, Srivannaboon K, et al. Risk factors for development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003;88:611-616. (Pubitemid 36207799)
31. Sorva R. Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 1988; 77:587-592.
32. Lorini R, Cortona L, Saramuzza A, et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 1995;15:873-877.
33. Tracy RE, Newman WP, Wattigney WA, et al. Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: The Bogalusa Heart Study. Atherosclerosis 1995;116:163-179.
34. Pletcher MJ, Bibbins-Domingo K, Lewis CE, et al. Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med 2008;149:91-99. (Pubitemid 352035334)
35. Gustavsen PH, Høegholm A, Bang LE, et al. White coat hypertension is a cardiovascular risk factor: A 10-year follow-up study. J Hum Hypertens 2003;17:811-817. (Pubitemid 38028637)
36. Mikkola I, Keinänen-Kiukaanniemi S, Laakso M, et al. Metabolic syndrome in connection with BMI in young Finnish male adults. Diabetes Res Clin Pract 2007;76:404-409. (Pubitemid 46505038)
37. Mattsson N, Rönnemaa T, Juonala M, et al. The prevalence of metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J Intern Med 2007;261:159-169. (Pubitemid 46090324)
38. Tsouli SG, Liberopoulos EN, Mikhailidis DP, et al. Elevated serum uric acid levels in metabolic syndrome: An active component or an innocent bystander? Metabolism 2006;55:1293-1301.
39. Schachter M. Uric acid and hypertension. Curr Pharm Des 2005;11:4139-4143.
40. Yoo TW, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005;69:928-933. (Pubitemid 41124260)